suPARnostic® is prognostic across diseases

suPAR is a universal biomarker. The suPAR level is associated with the presence, severity, and progression of the disease, and in unselected patients, suPAR is one of the strongest prognostic biomarkers available to date.

The suPAR-level is, across diseases, directly linked to morbidity and mortality and can therefore be used to distinguish between non-survivors and survivors.

Read 1000+ published suPAR studies in leading medical journals

suPAR and inflammation in Nature Medicine medical and scientific Journal
suPAR and inflammation in The New England Journal of Medicine
suPAR and inflammation in Science AAAS Journal
suPAR and inflammation in JAMA medical and scientific journal

The suPARnostic® brand consists of three products:

Quick Triage

A Point of Care Solution

Quick Triage

Turbi-Latex

For Automated Systems

TurbiLatex

ELISA Assay

Clinical and Research

ELISA
suPARnostic® by ViroGates